"NOMIS is all about enabling outstanding talent to take on high-risk research."
- Georg Heinrich “Heini” Thyssen, NOMIS Founder
Search

NOMIS News

Aging Cell: “The mitochondrial ATP synthase is a shared drug target for aging and dementia”
NOMIS Foundation logo
NOMIS welcomes Ruben Garcia Santos as head of Scientific Affairs and Innovation Networks
Aeon: “‘Let the soul dangle’: how mind-wandering spurs creativity”
NZZ: “On the trail of the fountain of youth”
The collaborator: NOMIS researcher Eric Reiman is on a quest to prevent Alzheimer’s disease by sharing big data
EurekAlert!: “Essential quantum computer component downsized by two orders of magnitude”
Sebastian Zeidler and Ingrid Vendrell-Ferran named NOMIS fellows at eikones
Tages Anzeiger: “The cerebral man”
NOMIS Foundation logo
NOMIS celebrates its Distinguished Scientist Award 2017 winners
NOMIS Foundation logo
Photo gallery
NZZ: “What Neandertals have to do with today’s diseases”
TIME: “Elizabeth Blackburn: First woman to become president of the Salk Institute”
Protein turnover could be clue to living longer
PEGASuS grant recipients announced
NOMIS Awardee Karl Deisseroth wins 4 million euro Fresenius Research Prize
New NOMIS Foundation Chair and director of the NOMIS Center for Immunobiology and Microbial Pathogenesis
The New York Times: Benjamin R. Barber, Author of ‘Jihad vs. McWorld,’ Dies at 77
Die Zeit: “Youth is in our blood”
“… it is only in an environment in which you feel safe and at ease that you dare to express crazy ideas — there is nothing more stifling than fear.”
“Success, at least the kind that I want to see — the creativity, the brilliance, the vision — can’t be told from bibliometric indicators or grades.”
Nature Communications: “Cardiac afferent activity modulates the expression of racial stereotypes”
Load More